Cargando…
Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients
PURPOSE: Detecting malignant peripheral nerve sheath tumors (MPNSTs) remains difficult. (18)F-FDG PET-CT has been shown helpful, but ideal threshold values of semi-quantitative markers remain unclear, partially because of variation among scanners. Using EU-certified scanners diagnostic accuracy of i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860956/ https://www.ncbi.nlm.nih.gov/pubmed/35025020 http://dx.doi.org/10.1007/s11060-021-03936-y |
_version_ | 1784654777851838464 |
---|---|
author | Geitenbeek, Ritch T. J. Martin, Enrico Graven, Laura H. Broen, Martijn P. G. Anten, Monique H. M. E. van der Pol, Jochem A. J. Verhoef, Cornelis Taal, Walter |
author_facet | Geitenbeek, Ritch T. J. Martin, Enrico Graven, Laura H. Broen, Martijn P. G. Anten, Monique H. M. E. van der Pol, Jochem A. J. Verhoef, Cornelis Taal, Walter |
author_sort | Geitenbeek, Ritch T. J. |
collection | PubMed |
description | PURPOSE: Detecting malignant peripheral nerve sheath tumors (MPNSTs) remains difficult. (18)F-FDG PET-CT has been shown helpful, but ideal threshold values of semi-quantitative markers remain unclear, partially because of variation among scanners. Using EU-certified scanners diagnostic accuracy of ideal and commonly used (18)F-FDG PET-CT thresholds were investigated and differences between adult and pediatric lesions were evaluated. METHODS: A retrospective cohort study was performed including patients from two hospitals with a clinical or radiological suspicion of MPNST between 2013 and 2019. Several markers were studied for ideal threshold values and differences among adults and children. A diagnostic algorithm was subsequently developed. RESULTS: Sixty patients were included (10 MPNSTs). Ideal threshold values were 5.8 for SUVmax (sensitivity 0.70, specificity 0.92), 5.0 for SUVpeak (sensitivity 0.70, specificity 0.97), 1.7 for TLmax (sensitivity 0.90, specificity 0.86), and 2.3 for TLmean (sensitivity 0.90, specificity 0.79). The standard TLmean threshold value of 2.0 yielded a sensitivity of 0.90 and specificity of 0.74, while the standard SUVmax threshold value of 3.5 yielded a sensitivity of 0.80 and specificity of 0.63. SUVmax and adjusted SUV for lean body mass (SUL) were lower in children, but tumor-to-liver ratios were similar in adult and pediatric lesions. Using TLmean > 2.0 or TLmean < 2.0 and SUVmax > 3.5, a sensitivity and specificity of 1.00 and 0.63 can be achieved. CONCLUSION: (18)F-FDG PET-CT offers adequate accuracy to detect MPNSTs. SUV values in pediatric MPNSTs may be lower, but tumor-to-liver ratios are not. By combining TLmean and SUVmax values, a 100% sensitivity can be achieved with acceptable specificity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-021-03936-y. |
format | Online Article Text |
id | pubmed-8860956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-88609562022-02-23 Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients Geitenbeek, Ritch T. J. Martin, Enrico Graven, Laura H. Broen, Martijn P. G. Anten, Monique H. M. E. van der Pol, Jochem A. J. Verhoef, Cornelis Taal, Walter J Neurooncol Clinical Study PURPOSE: Detecting malignant peripheral nerve sheath tumors (MPNSTs) remains difficult. (18)F-FDG PET-CT has been shown helpful, but ideal threshold values of semi-quantitative markers remain unclear, partially because of variation among scanners. Using EU-certified scanners diagnostic accuracy of ideal and commonly used (18)F-FDG PET-CT thresholds were investigated and differences between adult and pediatric lesions were evaluated. METHODS: A retrospective cohort study was performed including patients from two hospitals with a clinical or radiological suspicion of MPNST between 2013 and 2019. Several markers were studied for ideal threshold values and differences among adults and children. A diagnostic algorithm was subsequently developed. RESULTS: Sixty patients were included (10 MPNSTs). Ideal threshold values were 5.8 for SUVmax (sensitivity 0.70, specificity 0.92), 5.0 for SUVpeak (sensitivity 0.70, specificity 0.97), 1.7 for TLmax (sensitivity 0.90, specificity 0.86), and 2.3 for TLmean (sensitivity 0.90, specificity 0.79). The standard TLmean threshold value of 2.0 yielded a sensitivity of 0.90 and specificity of 0.74, while the standard SUVmax threshold value of 3.5 yielded a sensitivity of 0.80 and specificity of 0.63. SUVmax and adjusted SUV for lean body mass (SUL) were lower in children, but tumor-to-liver ratios were similar in adult and pediatric lesions. Using TLmean > 2.0 or TLmean < 2.0 and SUVmax > 3.5, a sensitivity and specificity of 1.00 and 0.63 can be achieved. CONCLUSION: (18)F-FDG PET-CT offers adequate accuracy to detect MPNSTs. SUV values in pediatric MPNSTs may be lower, but tumor-to-liver ratios are not. By combining TLmean and SUVmax values, a 100% sensitivity can be achieved with acceptable specificity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-021-03936-y. Springer US 2022-01-13 2022 /pmc/articles/PMC8860956/ /pubmed/35025020 http://dx.doi.org/10.1007/s11060-021-03936-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Study Geitenbeek, Ritch T. J. Martin, Enrico Graven, Laura H. Broen, Martijn P. G. Anten, Monique H. M. E. van der Pol, Jochem A. J. Verhoef, Cornelis Taal, Walter Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients |
title | Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients |
title_full | Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients |
title_fullStr | Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients |
title_full_unstemmed | Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients |
title_short | Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients |
title_sort | diagnostic value of (18)f-fdg pet-ct in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860956/ https://www.ncbi.nlm.nih.gov/pubmed/35025020 http://dx.doi.org/10.1007/s11060-021-03936-y |
work_keys_str_mv | AT geitenbeekritchtj diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients AT martinenrico diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients AT gravenlaurah diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients AT broenmartijnpg diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients AT antenmoniquehme diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients AT vanderpoljochemaj diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients AT verhoefcornelis diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients AT taalwalter diagnosticvalueof18ffdgpetctindetectingmalignantperipheralnervesheathtumorsamongadultandpediatricneurofibromatosistype1patients |